{"keywords":["ALK","Crizotinib","Denosumab","NF-kB","Non small cell lung cancer","RANK","RANKL"],"meshTags":["Antibodies, Monoclonal, Humanized","Bronchoscopy","Carcinoma, Non-Small-Cell Lung","Cough","DNA Mutational Analysis","Denosumab","Genes, erbB-1","Humans","Lung Neoplasms","Male","Middle Aged","Mutation","Neoplasm Metastasis","Neoplasm Staging","RANK Ligand","Receptor Protein-Tyrosine Kinases","Remission Induction","Tomography, X-Ray Computed"],"meshMinor":["Antibodies, Monoclonal, Humanized","Bronchoscopy","Carcinoma, Non-Small-Cell Lung","Cough","DNA Mutational Analysis","Denosumab","Genes, erbB-1","Humans","Lung Neoplasms","Male","Middle Aged","Mutation","Neoplasm Metastasis","Neoplasm Staging","RANK Ligand","Receptor Protein-Tyrosine Kinases","Remission Induction","Tomography, X-Ray Computed"],"genes":["ALK gene","ALK","RANK"],"organisms":["9606","9606"],"publicationTypes":["Case Reports","Journal Article"],"abstract":"Here we report the case of a patient with metastatic adenocarcinoma of the lung harboring an ALK gene translocation. In this patient a response of the primary tumor and metastases has been detected upon treatment with denosumab. A possible link between ALK and RANK is postulated. ","title":"Primary non-small cell lung cancer response upon treatment with denosumab.","pubmedId":"24075124"}